Literature DB >> 11994674

Melanocortin pathway: animal models of obesity and disease.

D L Marks1, A A Butler, R D Cone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11994674

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN： 0003-4266            Impact factor:   2.478


× No keyword cloud information.
  4 in total

Review 1.  The melanocortin system and energy balance.

Authors:  Andrew A Butler
Journal:  Peptides       Date:  2006-01-23       Impact factor: 3.750

2.  A derivative of the melanocortin receptor antagonist SHU9119 (PG932) increases food intake when administered peripherally.

Authors:  Gregory M Sutton; M Josephine Babin; Xuyuan Gu; Victor J Hruby; Andrew A Butler
Journal:  Peptides       Date:  2007-10-24       Impact factor: 3.750

3.  Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction.

Authors:  I Côté; Y Sakarya; N Kirichenko; D Morgan; C S Carter; N Tümer; P J Scarpace
Journal:  Can J Physiol Pharmacol       Date:  2016-10-19       Impact factor: 2.273

4.  Intermittent MTII application evokes repeated anorexia and robust fat and weight loss.

Authors:  Yi Zhang; Renata Collazo; Yongxin Gao; Gang Li; Philip J Scarpace
Journal:  Peptides       Date:  2009-12-23       Impact factor: 3.750
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.